These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8209799)
21. The deregulatory effects of preempting tort litigation: FDA regulation of medical devices. Gostin LO JAMA; 2008 May; 299(19):2313-6. PubMed ID: 18492972 [No Abstract] [Full Text] [Related]
22. FDA reveals plans for antimicrobial susceptibility monitoring. Tollefson L J Am Vet Med Assoc; 1996 Feb; 208(4):459-60. PubMed ID: 8603884 [No Abstract] [Full Text] [Related]
23. Report: FDA exerts too little oversight of researchers' conflicts of interest. Kuehn BM JAMA; 2009 Feb; 301(7):709-10. PubMed ID: 19224741 [No Abstract] [Full Text] [Related]
24. Instrumentation for antimicrobic susceptibility testing: yesterday, today, and tomorrow. Amsterdam D Diagn Microbiol Infect Dis; 1988 Mar; 9(3):167-78. PubMed ID: 3293893 [No Abstract] [Full Text] [Related]
25. FDA evaluation of antimicrobials: subgroup analysis. Powers JH; Lin D; Ross D Chest; 2005 Jun; 127(6):2298-9; authore reply 2300-1. PubMed ID: 15947370 [No Abstract] [Full Text] [Related]
26. [Old and new activities of the FDA in the control of the pacemaker industry]. Obino S G Ital Cardiol; 1978; 8 Suppl 3():119. PubMed ID: 755735 [No Abstract] [Full Text] [Related]
27. Drug approval process and FDA. Schmidt AM N Y State J Med; 1976 Nov; 76(12):2039-42. PubMed ID: 1069200 [No Abstract] [Full Text] [Related]
28. PROBLEMS RAISED FOR THE FDA BY THE OCCURRENCE OF THALIDOMIDE EMBRYOPATHY IN GERMANY, 1960-1961. KELSEY FO Am J Public Health Nations Health; 1965 May; 55(5):703-7. PubMed ID: 14287841 [No Abstract] [Full Text] [Related]
29. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT; Hagie F; Keen CL; Gershwin ME Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [TBL] [Abstract][Full Text] [Related]
30. Regulation of devices: a quickening pace. Phelps JR Med Instrum; 1980; 14(3):144-8. PubMed ID: 7382894 [TBL] [Abstract][Full Text] [Related]
31. New drugs: the AMA and the FDA. Appel JZ Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864 [No Abstract] [Full Text] [Related]
32. Evaluating EMS devices: FDA vs. private sector. Nobel JJ Emerg Dep News; 1980 Sep; 2(9):2, 5. PubMed ID: 10247890 [No Abstract] [Full Text] [Related]
33. FDA tells senators of doctors who fake data in clinical drug trials. Holden C Science; 1979 Oct; 206(4417):423-3. PubMed ID: 504984 [No Abstract] [Full Text] [Related]
34. FDA use of international standards in the premarket review process. Rechen E; Barth DJ; Marlowe D; Kroger L Biomed Instrum Technol; 1998; 32(5):518-26. PubMed ID: 9800008 [TBL] [Abstract][Full Text] [Related]
35. Gene therapy: US clinical trials imminent. Budiansky S Nature; 1984 Nov 29-Dec 5; 312(5993):393. PubMed ID: 6594577 [TBL] [Abstract][Full Text] [Related]
36. The role of resistance testing in clinical trial design and product labelling: a regulatory perspective. Laessig KA; Murray JS; Chikami G Antivir Ther; 2000 Mar; 5(1):77-83. PubMed ID: 10846597 [TBL] [Abstract][Full Text] [Related]
37. The Dalkon shield story. Levinson CJ; Richardson DC Adv Plan Parent; 1976; 11(2):53-63. PubMed ID: 789156 [No Abstract] [Full Text] [Related]
38. Pediatric drug development in anesthesiology: an FDA perspective. Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624 [No Abstract] [Full Text] [Related]
39. Device development and FDA scientific review. Pilot LR Med Instrum; 1983; 17(5):341-2. PubMed ID: 6646019 [TBL] [Abstract][Full Text] [Related]
40. Manufacture, packing, storage and installation of medical devices: regulations establishing good manufacturing practices. Fed Regist; 1978 Jul; 43(141 Pt 1):31507-32. PubMed ID: 10237249 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]